Cyclophosphamide-Using Nonmyeloablative Allogeneic Cell Therapy against Renal Cancer with a Reduced Risk of Graft-versus-Host Disease

Purpose: Much attention has been paid to nonmyeloablative allogeneic stem cell transplantation for the treatment of renal cancer. We recently proposed a cyclophosphamide-using nonmyeloablative cell therapy in which donor lymphocyte infusion (DLI) was carried out after the tolerance induction to dono...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical cancer research 2007-02, Vol.13 (3), p.1029-1035
Hauptverfasser:	ETO, Masatoshi, HARANO, Masahiko, TATSUGAMI, Katsunori, HARADA, Mamoru, KAMIRYO, Yoriyuki, KIYOSHIMA, Keijiro, HAMAGUCHI, Masumitsu, TSUNEYOSHI, Masazumi, YOSHIKAI, Yasunobu, NAITO, Seiji
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antineoplastic agents Antineoplastic Agents - pharmacology Antineoplastic Agents, Alkylating - pharmacology Biological and medical sciences bone marrow transplantation Cell Transplantation - methods cyclophosphamide Cyclophosphamide - pharmacology Female Graft vs Host Disease - drug therapy GVT effect Humans Kidney Neoplasms - drug therapy Kidneys Lymphocytes - metabolism Male Medical sciences Mice Mice, Inbred BALB C Mice, Inbred DBA mixed chimerism Nephrology. Urinary tract diseases Pharmacology. Drug treatments renal cell carcinoma Risk Tumors of the urinary system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!